Turnstone Biologics Corp. (TSBX)
NASDAQ: TSBX · Real-Time Price · USD
0.3481
+0.0136 (4.07%)
At close: Jun 16, 2025, 4:00 PM
0.3482
+0.0001 (0.03%)
After-hours: Jun 16, 2025, 4:00 PM EDT

Turnstone Biologics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-63.01-70.84-55.2-30.8333.27
Depreciation & Amortization
1.631.842.83.91.39
Loss (Gain) From Sale of Assets
2.870.530.32--
Asset Writedown & Restructuring Costs
--1.580.5-
Loss (Gain) From Sale of Investments
-1.07-1.86-2.06-0.10.54
Stock-Based Compensation
2.963.684.226.422.61
Other Operating Activities
-0.88-0.820.117.022.31
Change in Accounts Receivable
-0.198.53-2.01-2.37
Change in Accounts Payable
0.270.83-3.43.41-2.16
Change in Unearned Revenue
---19.31-53.1-81.94
Change in Income Taxes
-----0.1
Change in Other Net Operating Assets
0.17-0.98-3.75-6.260.81
Operating Cash Flow
-57.07-67.44-66.15-71.06-45.63
Capital Expenditures
-0.09-0.23-1.25-5.17-3.41
Sale of Property, Plant & Equipment
0.040.030.45--
Investment in Securities
64.5278.76-27.3-9.760.06
Investing Cash Flow
64.4778.56-28.09-14.93-3.35
Issuance of Common Stock
0.040.0477.940.160.34
Other Financing Activities
-0.03-0.03-0.9-2.81-
Financing Cash Flow
0.010.0177.05-2.6679.95
Net Cash Flow
7.4111.13-17.2-88.6530.98
Free Cash Flow
-57.15-67.67-67.4-76.23-49.04
Free Cash Flow Margin
---349.12%-104.00%-48.41%
Free Cash Flow Per Share
-2.48-2.94-5.83-30.68-18.16
Cash Income Tax Paid
0.080.20.10.082.01
Levered Free Cash Flow
-36.05-40.89-45.82-31.3-
Unlevered Free Cash Flow
-36.05-40.89-45.82-31.3-
Change in Net Working Capital
1.930.3514.7621.07-
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q